Elżbieta Moszczyńska

Elżbieta Moszczyńska

Auto-generated profile, based on publicly available information

Elżbieta Moszczyńska

Department of Endocrinology and Diabetology The Children's Memorial Health Institute Warsaw Poland

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2021 in Journal of Clinical Research in Pediatric Endocrinology
Verified
Journal Article
Open access
PDF file
MPMonika Prokop-Piotrkowska
Monika Prokop-Piotrkowska
KMKamila Marszałek-Dziuba
Kamila Marszałek-Dziuba
EMElżbieta Moszczyńska
Elżbieta Moszczyńska
MSMieczysław Szalecki
Mieczysław Szalecki
EJElzbieta Jurkiewicz
Elzbieta Jurkiewicz
Bone age is one of biological indicators of maturity used in clinical practice and it is a very important parameter of a child's assessment, especially in paediatric endocrinology. The most widely used method of bone age assessment is by performing a hand and wrist radiograph and its analysis with Greulich-Pyle or Tanner-Whitehouse atlases, although it has been about 60 years since they were published. Due to the progress in the area of Computer-Aided Diagnosis and application of artificial intelligence in medicine, lately, numerous programs for automatic bone age assessment have been created. Most of them have been verified in clinical studies in comparison to traditional methods showing good precision while eliminating inter- and intra-rater variability and reducing significantly the time of assessment. Also, there are available methods of assessment of bone age without X-ray exposure, like via ultrasound devices or MRI.

4 April 2017 in BMC Cancer
Verified
Journal Article
Open access
PDF file
JTJoanna Trubicka
Joanna Trubicka
TŻTomasz Żemojtel
Tomasz Żemojtel
JHJochen Hecht
Jochen Hecht
KFKatarzyna Falana
Katarzyna Falana
DPDorota Piekutowska-Abramczuk
Dorota Piekutowska-Abramczuk
MLMaria Lastowska
Maria Lastowska
The defects in DNA repair genes are potentially linked to development and response to therapy in medulloblastoma. Therefore the purpose of this study was to establish the spectrum and frequency of germline variants in selected DNA repair genes and their impact on response to chemotherapy in medulloblastoma patients. The following genes were investigated in 102 paediatric patients: MSH2 and RAD50 using targeted gene panel sequencing and NBN variants (p.I171V and p.K219fs*19) by Sanger sequencing. In three patients with presence of rare life-threatening adverse events (AE) and no detected variants in the analyzed genes, whole exome sequencing was performed. Based on combination of molecular and immunohistochemical evaluations tumors were divided into molecular subgroups. Presence of variants was tested for potential association with the occurrence of rare life-threatening AE and other clinical features. We have identified altogether six new potentially pathogenic variants in MSH2 (p.A733T and p.V606I), RAD50 (p.R1093*), FANCM (p.L694*), ERCC2 (p.R695C) and EXO1 (p.V738L), in addition to two known NBN variants. Five out of twelve patients with defects in either of MSH2, RAD50 and NBN genes suffered from rare life-threatening AE, more frequently than in control group (p = 0.0005). When all detected variants were taken into account, the majority of patients (8 out of 15) suffered from life-threatening toxicity during chemotherapy. Our results, based on the largest systematic study performed in a clinical setting, provide preliminary evidence for a link between defects in DNA repair genes and treatment related toxicity in children with medulloblastoma. The data suggest that patients with DNA repair gene variants could need special vigilance during and after courses of chemotherapy.

1 January 1997 in Hormone Research
Verified
Journal Article
Closed access
PDF file
MEMałunowicz E.M.A
Małunowicz E.M.A
MZMitkowska Z.C
Mitkowska Z.C
BKBal K.D
Bal K.D
NTNiżankowska-Błaż T.E
Niżankowska-Błaż T.E
MEMoszczyńska E.B
Moszczyńska E.B
RTRomer T.E.B
Romer T.E.B
A simplified urinary marker analysis for diagnosis of congenital adrenal hyperplasia (CAH) and 5α-reductase deficiency in infancy by GC/MS-SIM is introduced. The analysis was performed in 161 patients aged 3-90 days, 99 females and 62 males. CAH due to 21-hydroxylase deficiency was diagnosed in 61 patients (42 females and 19 males; in 10 cases simple virilizing form and in 51 patients salt-wasting form) and CAH induced by 3β-hydroxysteroid dehydrogenase deficiency without salt loss in 1 female patient. In 2 full-term newborns and 6 preterm infants, a false-positive diagnosis of CAH, which had been based on serum steroid evaluation, was made. In these cases, increased excretion of fetal adrenal zone steroids was confirmed as a possible source of false-positive serum 11-deoxycortisol and 17α-hydroxyprogesterone values. Lack of fetal adrenal zone steroid metabolites in 2 male newborns with salt loss symptoms led to the diagnosis of adrenal insufficiency due to X-linked adrenal hypoplasia and adrenal hemorrhage. A single analysis of urinary CAH markers by the very sensitive and selective GC/MS-SIM method can replace numerous assays of various steroids that must be carried out for positive diagnosis of abnormal steroidogenesis in infancy.

7 February 2020 in Child's Nervous System
Verified
Journal Article
Open access
PDF file
EMElżbieta Moszczyńska
Elżbieta Moszczyńska
MPMonika Prokop-Piotrkowska
Monika Prokop-Piotrkowska
ABAgnieszka Bogusz-Wójcik
Agnieszka Bogusz-Wójcik
WGWiesława Grajkowska
Wiesława Grajkowska
SSSylwia Szymańska
Sylwia Szymańska
MSMieczysław Szalecki
Mieczysław Szalecki
Purpose: Craniopharyngioma is one of the most frequent benign tumours of the central nervous system in the paediatric population. Although it is a benign tumour according to the WHO classification, it significantly deteriorates the patient’s quality of life. The aim of this study is to assess if proliferation index Ki67 can be a useful marker of the risk of craniopharyngioma’s recurrence.Methods: Expression of Ki67 was examined in 85 specimens of primary craniopharyngioma and in 11 specimens of the recurring tumour. In all the cases, adamantinomatous type of craniopharyngioma was diagnosed. Values of Ki67 expression were compared between patients with and without recurrence, between patients with progression and relapse and between primary and recurrent tumours.Results: No statistically significant differences were found between proliferation index Ki67 values in tumours with recurrence and without (median values 2.5% and 3%, respectively,p = 0.69). The median value of proliferation index Ki67 in progression group was 1% and in the relapse group 4%; no statistical significance between those groups was found (p = 0.067). The median value of proliferation index Ki67 in primary tumours was 3% (0–20%) and in recurrent tumours it was 5% (0–14%). Despite the lack of statistical significance (p = 0.61), a tendency towards higher values of Ki67 in recurring tumours in comparison with primary tumours was shown.Conclusions: Proliferation index Ki67 is not a reliable prognostic factor of craniopharyngioma’s recurrence.

12 November 2020 in Journal of Pediatric Endocrinology and Metabolism
Verified
Journal Article
Closed access
PDF file
EMElżbieta Moszczyńska
Elżbieta Moszczyńska
KPKatarzyna Pasternak-Pietrzak
Katarzyna Pasternak-Pietrzak
MPMonika Prokop-Piotrkowska
Monika Prokop-Piotrkowska
AŚAnna Śliwińska
Anna Śliwińska
SSSylwia Szymanska
Sylwia Szymanska
MSMieczysław Szalecki
Mieczysław Szalecki
Objectives: Ectopic adrenocorticotropic syndrome (EAS) causes approximately 10–18% of cases of Cushing’s syndrome (CS) in adults, while in children it occurs much less frequently. Case presentation: We report two cases of neuroendocrine tumors (of the thymus and the appendix) in a 12-year-old boy and a 15-year-old girl who presented with the clinical features of CS. Elevated serum cortisol, ACTH, and chromogranin levels were observed in both patients. Diagnoses were made on the basis of a mass in the thymus/appendix region visualized with chest/abdominal CT scan and radiotracer accumulation in scintigraphy in the same areas. Histopathological examinations confirmed the diagnoses of NET. Conclusion: EAS is an extremely rare endocrine disorder. However, it should be taken into consideration in the diagnostic process of every case of ACTH-dependent CS.

13 April 2016 in Endokrynologia Polska
Verified
Journal Article
Open access
KKKarolina Kot
Karolina Kot
EMElżbieta Moszczyńska
Elżbieta Moszczyńska
ALAgnieszka Lecka-Ambroziak
Agnieszka Lecka-Ambroziak
MMMarek Migdał
Marek Migdał
MSMieczysław Szalecki
Mieczysław Szalecki
ROHHAD syndrome (Rapid-onset Obesity with Hypothalamic Dysfunction, Hypoventilation, and Autonomic Dysregulation) is characterised by rapid-onset obesity in young children, hypoventilation, and hypothalamic and autonomic dysfunction. The exact aetiology of the disease remains unknown, and the number of reported cases seems to be underestimated. We present the case of a nine-year-old male patient suspected of ROHHAD due to weight gain since early childhood, decreased height velocity, hypoventilation, hypodipsia, excessive perspiration, and pyrexial episodes. The presented symptoms, and laboratory and imaging findings met the criteria of ROHHAD syndrome. ROHHAD should be considered in differential diagnosis for obesity in children. Early identification of the disease prevents potential complications specific for the syndrome, in particular a life-threatening cardio-pulmonary arrest. Patients with ROHHAD require regular follow-up by a multidisciplinary team.